Madison Avenue Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$183M |
| 2 |
Icon
ICLR
|
+$175M |
| 3 |
MICC
The Magnum Ice Cream Company N.V.
MICC
|
+$81.3M |
| 4 |
AIV
Aimco
AIV
|
+$64.8M |
| 5 |
STAAR Surgical
STAA
|
+$46.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$460M |
| 2 |
Globus Medical
GMED
|
+$171M |
| 3 |
SOLS
Solstice Advanced Materials
SOLS
|
+$135M |
| 4 |
Indivior Pharmaceuticals
INDV
|
+$64.9M |
| 5 |
Unifirst Corp
UNF
|
+$58.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.8% |
| 2 | Technology | 17.36% |
| 3 | Consumer Staples | 12.97% |
| 4 | Industrials | 12.01% |
| 5 | Financials | 7.78% |
Similar funds
Madison Avenue Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Madison Avenue Partners held 30 positions worth $2.3B, down 1.2% from $2.33B the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Madison Avenue Partners withdrew a net $322M in Q1 2026, closing 3 positions and reducing 10 holdings. Its most notable exit was Solstice Advanced Materials, an estimated $135M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Madison Avenue Partners opened a new position in Coupang worth $177M.
- Madison Avenue Partners's largest Q1 2026 buy was Coupang: 9,363,621 shares worth $177M.
- Madison Avenue Partners added most to The Magnum Ice Cream Company N.V. in Q1 2026, an estimated $81.3M increase.
- Madison Avenue Partners's biggest Q1 2026 reduction was Sandisk, cutting an estimated $460M.
- Madison Avenue Partners fully exited Solstice Advanced Materials in Q1 2026, selling an estimated $135M.
- Madison Avenue Partners's ten largest holdings make up 78% of its $2.3B portfolio in Q1 2026.
- Madison Avenue Partners opened 7 new positions and closed 3 in Q1 2026.
- Madison Avenue Partners's portfolio value fell 1.2% quarter-over-quarter to $2.3B.
Based on Madison Avenue Partners's 13F filing for Q1 2026, filed 15 May 2026.